X0609 4 2026-04-23 0 0001642380 Insight Molecular Diagnostics Inc. IMDX 0001278386 BROADWOOD PARTNERS, L.P. false C/O BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0001278387 BROADWOOD CAPITAL INC false 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0001278388 Bradsher Neal C false C/O BROADWOOD CAPITAL, INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0 Common Stock, no par value 2026-04-23 4 P 0 280381 3.5025 A 12395081 D Common Stock, no par value 2026-04-23 4 P 0 0 0 A 12395081 I Footnote Common Stock, no par value 2026-04-24 4 P 0 38880 3.5258 A 12433961 D Common Stock, no par value 2026-04-24 4 P 0 0 0 A 12433961 I Footnote Common Stock, no par value 2026-04-27 4 P 0 250923 3.6391 A 12684884 D Common Stock, no par value 2026-04-27 4 P 0 0 0 A 12684884 I Footnote Common Stock, no par value 157 D Warrant to Purchase Common Stock 30.60 2027-04-19 Common Stock 150093 150093 D Warrant to Purchase Common Stock 30.60 2027-04-19 Common Stock 150093 150093 I Footnote The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be beneficially owned by each of: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher, as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. These securities are directly owned by Neal C. Bradsher. This constitutes the weighted average purchase price. The prices range from $3.39 to $3.54. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $3.47 to $3.59. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $3.50 to $3.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. These warrants are currently exercisable. Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 2026-04-27 Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 2026-04-27 Neal C. Bradsher, /s/ Neal C. Bradsher 2026-04-27